Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.74 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.74 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.74 |
| ▸ | MEN1 | O00255 | 1/20 | 0.74 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.74 |
| ▸ | SLC5A1 | P13866 | 1/20 | 0.52 |
| ▸ | SLC5A2 | P31639 | 1/20 | 0.52 |
| ▸ | GABRA2 | P47869 | 7/20 | 0.49 |
| ▸ | GABRB2 | P47870 | 7/20 | 0.49 |
| ▸ | CNR1 | P21554 | 3/20 | 0.48 |
| ▸ | CNR2 | P34972 | 3/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL219061 | 0.87 | KDM4E (0.69) | MAPTMAPK1KDM4EMEN1KMT2A | |
| SCHEMBL4074146 | 0.84 | KDM4E (0.65) | MAPTMAPK1KDM4EMEN1KMT2A | |
| SCHEMBL219356 | 0.83 | CNR1 (0.67) | MAPTMAPK1KDM4EMEN1KMT2A | |
| SCHEMBL6770416 | 0.82 | KDM4E (0.53) | MAPTMAPK1KDM4EMEN1KMT2A | |
| SCHEMBL6886607 | 0.82 | KDM4E (0.53) | MAPTMAPK1KDM4EMEN1KMT2A | |
| Hydrochloric Acid SCHEMBL6770419 | 0.81 | KDM4E (0.52) | MAPTMAPK1KDM4EMEN1KMT2A | |
| SCHEMBL5769070 | 0.81 | KDM4E (0.58) | MAPTMAPK1KDM4EMEN1KMT2A | |
| SCHEMBL24225739 | 0.80 | KDM4E (0.68) | MAPTMAPK1KDM4EMEN1KMT2A | |
| SCHEMBL13955262 | 0.80 | KDM4E (0.68) | MAPTMAPK1KDM4EMEN1KMT2A | |
| SCHEMBL5767445 | 0.79 | KDM4E (0.56) | MAPTMAPK1KDM4EMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040235926-A1 | Cannabinoid receptor ligands and uses thereof | PFIZER INC. | 2004-11-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040235926-A1 | Cannabinoid receptor ligands and uses thereof | CNR1, CNR2, GPR18 | MAPT 2665/4885MAPK1 2323/4885KDM4E 3327/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.